COVID-19: Raw material crunch pushes vaccine makers to look at indigenization

Bharat Biotech has signed up with a CSIR lab to develop a synthetic process route for adjuvant molecule TLR 7/8 to Covaxin, using locally available chemicals. As export restrictions aren#39;t making life easy, many firms are entering into domestic tie-ups like this.

from Moneycontrol Business News https://ift.tt/2QzU4lt